A detailed history of Tfg Asset Management Gp LTD transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 103,000 shares of KROS stock, worth $1.09 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
103,000
Holding current value
$1.09 Million
% of portfolio
0.52%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$15.64 - $70.0 $1.61 Million - $7.21 Million
103,000 New
103,000 $1.63 Million

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $273M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Tfg Asset Management Gp LTD Portfolio

Follow Tfg Asset Management Gp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfg Asset Management Gp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tfg Asset Management Gp LTD with notifications on news.